Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues.

Regul Pept

Department of Physiology, Medical School, University of the Basque Country, Leioa, Bilbao, Spain.

Published: September 2001

Enzymatic cleavage of some peptide hormones, neurotransmitters and neuromodulators could be implicated in the regulation of extra- and intracellular fluid volume and osmolality. Prolyl endopeptidase is known to hydrolyze several peptides, which act on hydromineral balance, such as angiotensins, bradykinin, vasopressin, oxytocin, thyrotropin-releasing hormone, neurotensin and opioids. In this work, we analyzed the effects of certain volume and/or osmotic changes in the activity of the soluble and membrane-bound prolyl endopeptidase in several brain areas, heart, lungs, kidney and adrenal and pituitary glands of the rat. Soluble prolyl endopeptidase activity was higher in the renal cortex of the chronic salt-loaded rats than in the control rats. In the water-deprived and polyethylene glycol-treated rats, heart particulate prolyl endopeptidase was lower than in the control rats. Particulate prolyl endopeptidase was also lower in the adrenal gland of the acute salt-loaded rats and in the brain cortex of the water-loaded rats than in the control rats. Data suggest that tissue-dependent peptide hydrolysis evoked by prolyl endopeptidase activity is involved in the water-electrolyte homeostasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-0115(01)00277-4DOI Listing

Publication Analysis

Top Keywords

prolyl endopeptidase
28
endopeptidase activity
12
control rats
12
salt-loaded rats
8
rats control
8
particulate prolyl
8
endopeptidase lower
8
prolyl
7
endopeptidase
7
rats
7

Similar Publications

In proteomics, postproline cleaving enzymes (PPCEs), such as prolyl endopeptidase (PEP) and neprosin, complement proteolytic tools because proline is a stop site for many proteases. But while aiming at using PEP in online proteolysis, we found that this enzyme also displayed specificity to reduced cysteine. By LC-MS/MS, we systematically analyzed PEP sources and conditions that could affect this cleavage preference.

View Article and Find Full Text PDF

Targeted degradation of Pin1 by protein-destabilizing compounds.

Proc Natl Acad Sci U S A

November 2024

Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA 92521.

The concept of targeted protein degradation is at the forefront of modern drug discovery, which aims to eliminate disease-causing proteins using specific molecules. In this paper, we explored the idea to design protein degraders based on the section of ligands that cause protein destabilization, hence that facilitate the cellular breakdown of the target. Our studies present covalent agents targeting Pin1, a cis-trans prolyl isomerase that plays a crucial role in tumorigenesis.

View Article and Find Full Text PDF
Article Synopsis
  • * A study on S9 peptidase from Bacillus subtilis (S9bs) has confirmed its carboxypeptidase activity, which was previously unclear, highlighting key structural elements essential for this function.
  • * The research also revealed S9bs forms stable tetramers and identified its molecular arrangement, providing insights that could aid in therapeutic and drug design related to S9 family enzymes.
View Article and Find Full Text PDF

BACKGROUND X-PROLYL AMINOPEPTIDASE 3: (XPNPEP3) mutations are known to cause nephronophthisis-like nephropathy-1 (NPHPL1), a rare autosomal-recessive kidney disease characterized by progressive kidney failure and cystic kidney disease in childhood. The full phenotypic spectrum associated with mutations in XPNPEP3 is not fully elucidated. CASE PRESENTATION: A 13-year-old Chinese female patient with intellectual disability presented with a 2-year history of convulsions and fatigue, with a recent episode of swelling, breathlessness, and nocturnal dyspnea lasting 10 days.

View Article and Find Full Text PDF

This current study aims to analyze the potential bioactivities possessed by the enzymatic hydrolysates of commercial bovine, porcine, and tilapia gelatins using bioinformatics in combination with in vitro and in vivo studies. The hydrolysate with superior inhibition of angiotensin converting enzyme (ACE) activity was used to treat the D-galactose (DG)-induced amnesic mice. In silico digestion of the gelatins led to the identification of peptide sequences with potential antioxidant, ACE-inhibitory, and anti-amnestic properties.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!